Search

Your search keyword '"Lamisse F"' showing total 168 results
Start Over Author "Lamisse F"
168 results on '"Lamisse F"'

6. Increased plasma fibrinolysis and tissue-type plasminogen activator/tissue-type plasminogen activator inhibitor ratios after ethanol withdrawal in chronic alcoholics

Author

Gabriel I, Maillot F, Delahousse B, Lamisse F, Schellenberg F, and Yves Gruel

Subjects
Adult, Male, medicine.medical_specialty, medicine.medical_treatment, Tissue plasminogen activator, Statistics, Nonparametric, chemistry.chemical_compound, Internal medicine, Fibrinolysis, medicine, Humans, Prospective Studies, Hemostasis, Triglyceride, Ethanol, business.industry, Cholesterol, T-plasminogen activator, Hematology, General Medicine, Middle Aged, Lipids, Surgery, Substance Withdrawal Syndrome, Alcoholism, Plasminogen Inactivators, Endocrinology, chemistry, Plasminogen activator inhibitor-1, Tissue Plasminogen Activator, Plasminogen activator inhibitor-2, business, Plasminogen activator, medicine.drug
Abstract

The effects of alcohol withdrawal on fibrinolysis were studied in 10 middle-aged male chronic alcoholics institutionalized for withdrawal therapy. All patients were sampled on admission [day 1 (D1)] and 21 days after alcohol withdrawal [day 22 (D22)]. The overall plasma fibrinolytic capacity (OFC) was assayed by measuring the ability of patient plasma to generate D-dimers from a standardized fibrin clot, and tissue-type plasminogen activator (t-PA) and t-PA inhibitor (PAI-1) levels were assayed together with serum cholesterol, triglyceride and cholesterol fractions. At D22, the OFC significantly increased in seven patients [D1 = 10 +/- 0.7 microg/h (mean +/- SD), D22 = 17 +/- 7.4 microg/h; P < 0.01], while t-PA and PAI-1 levels decreased in all patients but two (t-PA: D1 = 16.6 +/- 5 ng/ml, D22 = 10.2 +/- 3.8 ng/ml; P < 0.001; and PAI-1: D1 = 46 +/- 39 ng/ml, D22 = 21 +/- 28 ng/ml; P < 0.01). This study clearly demonstrates an increase in overall fibrinolytic activity after alcohol withdrawal, which is mainly due to a decrease in PAI-1 levels. These changes induced by alcohol abstinence might provide clear benefit by reducing the risk of thromboembolic events and particularly of stroke associated with elevated PAI-1 levels described in heavy drinkers.

Published
2001

7. [Cardiac abnormalities in a prospective series of 40 patients with type 2 diabetes]

Author

Barthélemy, B, Delarue, J, Babuty, D, Casset-Senon, D, Marchal, C, Fauchier, Laurent, Charniot, J, Fauchier, J, Cosnay, P, Lamisse, F, and Dorogoichenko, Aleksandra

Subjects
[SHS] Humanities and Social Sciences
Abstract

Cardiovascular mortality, the principal cause of early death in diabetics, is multifactorial. A prospective study was undertaken to analyse the different factors of excess cardiac complications in 40 patients with type 2 diabetes, whatever the symptomatology, by making an inventory of the cardiac abnormalities (systolic and diastolic left ventricular function, left ventricular hypertrophy, abnormalities of myocardial perfusion, heart rate variability and arrhythmias). Patients underwent 24 hour Holter monitoring, high amplification signal averaged electrocardiography, echocardiography, Thallium scintigraphy with a dipyridamole test followed by coronary angiography when positive. Patients were aged 60 +/- 8 years, diabetics for 11.8 +/- 6.8 years, and had associated cardiovascular risk factors: 85% were obese, 75% were hypertensive, 62.5% had hypercholesterolaemia and 60% were smokers. The HbA1C was 9.2 +/- 19%. An increased left ventricular mass was observed in 34.2% of patients. The left ventricular ejection fraction was normal (59.1 +/- 6.8%); 69.7% of patients had left ventricular diastolic dysfunction. Reduced heart rate variability was observed in 51.8% of cases. Late ventricular potentials were recorded on high amplification signal averaging in 39.5% of patients; 25.6% had significant ventricular extrasystoles and 52.2% had atrial extrasystoles. Twelve patients (45%) underwent Thallium myocardial scintigraphy with a positive dipyridamole test, 8 of whom had coronary lesions on angiography. The excess cardiac complications of diabetes is mainly due to ischaemic heart disease aggravated by autonomic neuropathy, left ventricular diastolic dysfunction, arrhythmias and left ventricular hypertrophy. In future, larger series are required to demonstrate that this detection can guide therapeutic intervention and reduce cardiac morbidity and mortality of diabetics.

Published
2000

8. Leucine metabolism following a peritoneal aminoacid load

Author

Cl. Maingourd, Jacques Delarue, Charles Couet, Michelle Pinault, M. Objois, Lamisse F, and Revues Inra, Import

Subjects
medicine.medical_specialty, [SDV.AEN] Life Sciences [q-bio]/Food and Nutrition, Endocrinology, Biochemistry, Leucine metabolism, Internal medicine, [SDV.BDD] Life Sciences [q-bio]/Development Biology, medicine, Biology, [SDV.BDLR] Life Sciences [q-bio]/Reproductive Biology
Published
1998

9. Effects of nutrition education on calcium intake in the elderly

Author

Constans, T., Delarue, J., Rivol, M., Theret, V., and Lamisse, F.

Subjects
Aging -- Health aspects -- Research, Nutrition disorders -- Research, Calcium, Dietary -- Health aspects -- Research, Nutritionally induced diseases -- Research, Food/cooking/nutrition, Research, Health aspects
Abstract

Osteoporosis is an age-related decrease in bone density that occurs in both sexes, especially in women within 15 to 20 years of menopause. This condition is responsible for an increase [...]

Published
1994

19. Metabolic effects of oral glucose in CAPD patients versus healthy subjects

Author

C. Maingourd, Jacques Delarue, Lamisse F, Ph. Bagros, Charles Couet, and Revues Inra, Import

Subjects
[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition, medicine.medical_specialty, Endocrinology, Internal medicine, Metabolic effects, [SDV.BDD] Life Sciences [q-bio]/Development Biology, medicine, Healthy subjects, Oral glucose, Biology, [SDV.BDLR] Life Sciences [q-bio]/Reproductive Biology
Published
1997

32. The contribution of naturally labelled C fructose to glucose appearance in humans.

Author

Delarue, J., Normand, S., Pachiaudi, C., Beylot, M., Lamisse, F., and Riou, J.

Abstract

Among monosaccharides, fructose has a small hyperglycaemic effect. In order to better explain the mechanisms which cause this metabolic property, we used tracers labelled with stable isotopes (deuterated glucose and naturally C labelled fructose) to quantify the overall glucose appearance, the rate of appearance in plasma of the C glucose synthesized from fructose, and the fructose oxidation in vivo in man during a 6-h period following ingestion of 0.5 and 1 g · kg fructose. Fructose had a very small effect on overall glucose appearance (NS). During the 6 h of the study, it was found that the overall glucose appearance was 0.87±0.06 and 0.89±0.06 g · kg (NS). The amount of glucose synthesized from fructose was 0.27±0.04 and 0.51±0.03 g · kg ( p<0.01) representing 31% and 57% of overall glucose appearance ( p<0.01); the non-fructose glucose production was 0.60±0.02 and 0.38±0.03 g · kg ( p<0.05) after the 0.5 and 1 g · kg load, respectively. Fructose oxidation was 0.28±0.03 and 0.59±0.07 g · kg after the 0.5 and 1 g · kg load respectively ( p<0.01) representing 56% and 59% of the fructose loads (NS). These data show that the low hyperglycaemic effect of fructose is explained by its very small effect on overall glucose appearance and that fructose has a sparing effect on glucose metabolism. [ABSTRACT FROM AUTHOR]

Published
1993
Full Text
View/download PDF

44. Hepatite a la pristinamycine

Author

Bacq, Y., primary, Constans, T., additional, Choutet, P., additional, Lhuintre, Y., additional, Furet, Y., additional, and Lamisse, F., additional

Published
1985
Full Text
View/download PDF

45. Tetanus

Author

Gautier, J., primary, Lamisse, F., additional, and Bagros, P., additional

Published
1972
Full Text
View/download PDF

46. BONE-MARROW APLASIA AND PRIMARY RUBELLA INFECTION

Author

A. Goudeau, Ginies G, Perrotin D, C.H. Binet, Choutet P, and Lamisse F

Subjects
Pathology, medicine.medical_specialty, Rubella Infection, business.industry, medicine, General Medicine, Bone Marrow Aplasia, business, Virology
Published
1979

49. [Diet for patients receiving long term corticosteroids].

Author

Lamisse F

Subjects
Adrenal Cortex Hormones therapeutic use, Humans, Hyperglycemia chemically induced, Hyperglycemia prevention & control, Obesity chemically induced, Obesity prevention & control, Osteoporosis chemically induced, Osteoporosis prevention & control, Time Factors, Weight Gain, Adrenal Cortex Hormones adverse effects, Diet standards, Food, Formulated standards
Published
2009

50. [Alcohol and nutrition].

Author

Maillot F, Farad S, and Lamisse F

Subjects
Basal Metabolism, Calorimetry, Indirect, Electrolytes metabolism, Energy Metabolism, Humans, Lipid Peroxidation, Trace Elements physiology, Vitamins physiology, Weight Loss, Alcoholism physiopathology, Ethanol adverse effects, Nutritional Physiological Phenomena
Abstract

Alcoholism and alcohol-associated organ injury is one of the major health problems worldwide. Alcohol may lead to an alteration in intermediary metabolism and the relation between alcohol intake and body weight is a paradox. The effect of alcohol intake on resting metabolic rate, assessed by indirect calorimetry, and lipid oxidation, is still controversial. Small quantities of ethanol seem to have no effect on body weight. Ingestion of moderate amounts may lead to an increase in body weight, via a lipid-oxidizing suppressive effect. Chronic intake of excessive amounts in alcoholics leads to a decrease in body weight, probably via increased lipid oxidation and energy expenditure. Chronic ethanol abuse alters lipid-soluble (vitamins A, D and E) and water-soluble (B-complex vitamins, vitamin C) vitamins status, and some trace elements status such as magnesium, selenium or zinc.

Published
2001
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results